Skip to main content
Clinical Trials/JPRN-jRCTs052210081
JPRN-jRCTs052210081
Recruiting
Phase 4

Multi Point Pacing and Continuous Atrioventricular Conduction OPtimization of Cardiac Resynchronization Therapy - PPAP-CRT

Kusano Kengo0 sites50 target enrollmentSeptember 9, 2021

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Heart failure(HF) patients who are indicated for CRT-D device
Sponsor
Kusano Kengo
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 9, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kusano Kengo

Eligibility Criteria

Inclusion Criteria

  • 1\. A patient who has never received CRT
  • 2\. A patient who is eligible for CRT according to the guideline of The Japanese Circulation Society(JCS) and scheduled for implantation of CRT\-D
  • 3\. A patient with a fixed residence who can follow the scheduled follow\-up
  • 4\. A patient who has signed and dated the informed consent

Exclusion Criteria

  • 1\. A patient who is suffering from AV block (excluding atrial conduction time 250 ms or more)
  • 2\. A patient who is suffering from chronic atrial fibrillation
  • 3\. A patient who underwent tricuspid valve surgery or has tricuspid cardiac surgery planned
  • 4\. A patients who has a life expectancy of less than 2 years with a non\-cardiac cause
  • 5\. A patient who is pregnant, breastfeeding or may become pregnant
  • 6\. A patient who is less than 20 years of age at the time of consent
  • 7\. A patient who is already included or will enroll in another interventional study during this study
  • 8\. A patient who is judged by the Principal Investigator (PI) or the Sub\-Investigator (SI) as ineligible for participation in this study due to another reason

Outcomes

Primary Outcomes

Not specified

Similar Trials